SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...

Fistulas and abscesses caused by ileitis can lead to pain in the lower right part of your abdomen. Treatment options for ileitis are like those for other types of Crohn’s disease. When fistulas ...

Noninvasive monitoring methods, such as enterography and ultrasound, are becoming increasingly recognized as essential tools ...

Crohn’s disease most commonly affects the small intestine ... Fistulas can begin as an infection in your digestive tract or result from abscesses or inflammation caused by ulcers or sores.

People with Crohn’s disease who have had a previous abdominal surgery may be more prone to developing adhesions. Adhesions can also develop from an abscess or fistula. Internal organs normally ...

Anal and perianal complications of Crohn's disease represent a major challenge ... fissures, ulcers, abscesses, fistulas, and stricture -- at times, disease can be so extensive that it leads ...

Medscape, January 15, 2025 Fast Five Quiz: Recognizing Spinal Abscess Can you properly identify ... Medscape, December 23, 2024 Fast Five Quiz: Crohn’s Disease Comorbidities Do you know how ...

The patient was a 62-year-old woman with a history of Crohn’s disease who was also undergoing antibiotic ... The pain in her shoulder was due to an abscess in the shoulder joint, which required ...

1 Analogous disease-modifying treatment goals for Crohn disease are currently being conceptualised and may include prevention of structural bowel damage (stricture, fistula, abscess) and impaired ...

A first-year nursing student at CNC has landed a national scholarship thanks to her efforts in the classroom and among the inflammatory bowel disease community. Wynne Fitzpatrick (Win) took home […] ...

GI abscess and perforation were observed, a specific focus of attention during future clinical development. Trial registration number NCT01287897 and NCT01345318. Crohn’s disease (CD) has no known ...